|Prof. Michael Barry MB, FRCPI, PhD
Prof. Michael Barry is a Consultant Clinical Pharmacologist and Head of the Department of Pharmacology & Therapeutics at the University of Dublin, Trinity College. He is the clinical director of the National Centre for Pharmacoeconomics which conducts pharmacoeconomic evaluations on medicines prior to reimbursement under the Community Drugs schemes in Ireland. He is Past-President (2010-2011) of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR). He was a board member of the Health Information and Quality Authority (HIQA) and is a member of a number of National Committees on pricing and reimbursement of medicines. Prof. Barry chairs the New Drugs Committee and the Medication Safety Committee at St. James’s Hospital, Dublin. In 2013 he was appointed as Clinical Lead for the new HSE Medicines Management Programme. He is a fellow of the Royal College of Physicians in Ireland and is a specialty trainer for Pharmacology & Therapeutics. His research areas include the cost-effectiveness of high cost drugs including chemotherapeutic agents and biologic drugs, pricing and reimbursement and performance based risk sharing schemes. He has published widely on the cost-effectiveness of medicines in the Irish healthcare setting.
|Deputy Head of NCPE:|
|Dr. Lesley Tilson BSc (Hons) Pharm, PhD
Dr. Lesley Tilson is Chief I Pharmacist at the National Centre for Pharmacoeconomics and is a graduate of the University of Brighton. She trained in the Chelsea and Westminster hospital, London and then worked as a resident pharmacist at the Oxford Radcliffe Hospitals NHS Trust. During this time she completed a Diploma in Clinical Pharmacy with Cardiff University. Lesley worked as a senior clinical pharmacist at St James’s Hospital Dublin, on the intensive care unit and cardiac surgery ward. She has a PhD from the Department of Pharmacology and Therapeutics, Trinity College Dublin (2002-2005) and a Diploma in Statistics from Trinity College Dublin (2003-2004). She is a lecturer in pharmacoeconomics to undergraduate and postgraduate pharmacy students. Research interests include: Economic evaluation of pharmaceuticals in the Irish setting, pharmaceutical pricing and reimbursement strategies, policies to promote generic markets, international pharmaceutical pricing, analysis of drug utilisation and expenditure trends. She received the ISPOR Bernie O’Brien New Investigator Award in May 2011.
|Current staff include:|
|Prof. Kathleen Bennett BSc, PhD (Statistics)
Professor Kathleen Bennett is Associate Professor in Biostatistics at the RCSI (Royal College of Surgeons in Ireland) Division of Population Health Sciences, and a Health Research Board (HRB) Research Leader. Professor Bennett leads a research team undertaking a programme of research titled “Statistical epidemiology in Population Health and Health Services Research: Quality and Patient Safety in Medicines”. Professor Bennett has over 25 years’ experience of undertaking medical research. After completing her BSc in mathematics and statistics at Southampton University, UK she spent 2 years working as a clinical trials statistician in the Pharmaceutical Industry before returning to Southampton to complete a PhD. She was employed as an epidemiologist/statistician in the Department of Pharmacology and Therapeutics, Trinity College Dublin for many years and retains a part-time position in the Department. Professor Bennett is an advisor to the National Centre for Pharmacoeconomics on pharmacoepidemiology and statistics.
|Niamh Carey BSc (Pharm), MPharm, MSc (Health Economics)
Niamh Carey is a Research Fellow at the National Centre for Pharmacoeconomics. She is a graduate of the School of Pharmacy, Trinity College Dublin and also holds a Masters of Pharmacy degree from the Royal College of Surgeons in Ireland. Her previous experience lies primarily in community pharmacy where she worked following completion of her MPharm studies. During this time, she obtained a Masters in Health Economics from the National University of Ireland Galway. Niamh is currently undertaking a PhD at the NCPE, focusing on the area of health technology assessment.
|Dr. Emer Fogarty BSc Pharm, Dip (Stat), MSc, PhD
Emer Fogarty is acting Chief II Pharmacist and a member of the economic review group at the National Centre for Pharmacoeconomics. She graduated from Trinity College, Dublin in 2004 and completed an MSc in Clinical Pharmacy with University College, Cork. Formerly employed as a clinical pharmacist in St. James’s Hospital, Emer worked in numerous clinical pharmacy specialities including general medicine, oncology, and infectious diseases. She completed a PhD examining the cost-effectiveness of treatments for multiple sclerosis, and her research interests are comparative effectiveness and health economic modelling.
Niamh is the office administrator for the National Centre for Pharmacoeconomics. She completed a computer/receptionist course in Crumlin College of Business and Technical studies in 1989. Prior to starting in St. James’s Hospital in 1996 Niamh had been working for a private orthodontist for six years. Since joining St. James’s Hospital she has worked in various different departments including the Central Pathology Laboratory and Personnel (Human Resources). She also spent time working with the National Medicines Information Centre before joining the National Centre for Pharmacoeconomics (NCPE) in 2000.Email: email@example.com
Claire Gorry is a graduate of the School of Pharmacy, Trinity College Dublin. She completed a community pharmacy pre-registration placement and has since gained experience in community, hospital and industry roles. Most recently she has worked as haematology/oncology clinical trials pharmacist in St James hospital. Claire has completed a post graduate diploma in Clinical Pharmacy from Queen’s University Belfast and a diploma in Health Economics from University College Dublin. Claire is currently undertaking a PhD in the NCPE, researching the cost effectiveness of treatments for metastatic melanoma.
|Alma Hanevy BSc Pharm, MSc (Hospital Pharmacy)
Alma is the stakeholder engagement lead for rare diseases and is a Chief II pharmacist at the National Centre for Pharmacoeconomics. Alma is a graduate of the School of Pharmacy, Trinity College Dublin and has completed the MSc in Hospital Pharmacy from Trinity College Dublin. Formerly employed as a clinical pharmacist in Tallaght hospital and the Mater hospital Dublin, Alma worked in numerous clinical pharmacy specialities. Most recently, she has worked as a Senior medicines information pharmacist in the National Medicines Information Centre (NMIC) Dublin, and has over 1 1 years experience working in medicines information.
|Dr. Felicity Lamrock
Dr. Felicity Lamrock is a statistician at the National Centre for Pharmacoeconomics, and an Adjunct Researcher at the Institute for Public Health, Medical Decision Making and HTA at the University for Health Sciences Informatics and Technology (UMIT), Austria. Felicity is a graduate of Queen’s University Belfast, where she completed her BSc in Mathematics with Statistics and Operational Research in 2012. She also completed her PhD in Medical Statistics from Queen’s University Belfast which involved developing new statistical methodology and creating a model to test the cost-effectiveness of a panel of novel biomarkers to prevent cardiovascular disease. This work was undertaken through the BiomarCaRE project co-funded by the European Community’s Seventh Framework Programme. Her on-going research interests include combining techniques within the decision modelling, health economics and Markov process literature.
|Dr. Laura McCullagh BSc (Hons) Pharm, Dip., PhD
In January 2016, Laura was appointed to the post of Associate Professor of Pharmacoeconomics & Health Technology Assessment within the Department of Pharmacology & Therapeutics. She is a member of the National Centre for Pharmacoeconomics (NCPE) Review Group for economic evaluations. Previous roles have included a HRB Research Fellow within the Department of Pharmacology & Therapeutics, a Chief II in St James’s Hospital, Dublin and a Senior Medicines Information Pharmacist, Oxford Radcliffe Trust, Uk. Laura holds a PhD from the Department of Pharmacology & Therapeutics for her research which focused on Health Technology Assessment within the Irish Healthcare Setting. She is a graduate of the Sunderland School of Pharmacy. She completed her diploma in hospital pharmacy at De Monfort University, Leicester. Research interests include Pharmacoeconomic Evaluations, Value of Information Analysis and Survival Analysis.
|Caitríona Ní Choitir (MPharm, MSc)
Caitríona Ní Choitir is a Senior Research Fellow at the National Centre for Pharmacoeconomics. A member of the NCPE review group team, Caitríona is also the national clinical data manager for the Irish Hepatitis C Treatment Registry. She holds a Masters in Pharmacy degree from the Robert Gordon University of Aberdeen and an MSc in International Health Policy and Health Economics from the London School of Economics and Political Science. Prior to joining the NCPE, Caitríona worked as a data analytics and service improvement consultant in the NHS and as a senior health economics and outcomes research consultant in the pharmaceutical industry. Caitríona is presently a member of the Council of Clinical Information Officers, eHealth Ireland. Research interests include; pharmaceutical economics and policy, outcomes research and methods for the economic evaluation of technologies and health care.
|Helen O’Donnell BSc Pharm, MPharm, MSc (Health Economics)
Helen O’Donnell is a research pharmacist at the National Centre for Pharmacoeconomics. Helen is a graduate of Trinity College Dublin where she was elected a scholar. She completed her MPharm studies at the Royal College of Surgeons in Ireland. After qualifying as a pharmacist in 2012, Helen worked in community pharmacy before undertaking a Masters in Health Economics in National University of Ireland Galway. She is currently undertaking a PhD examining the cost-effectiveness of lipid lowering treatments in Ireland.
|Dr. Aisling O Leary BSc Pharm, PhD
Dr. O’Leary MPSI, a graduate of the School of Pharmacy, Dublin University, Trinity College with a Ph.D in pharmaceutical chemistry, is a Chief II pharmacist in the centre. Her background is predominantly in hospital pharmacy where she worked in a variety of clinical disciplines including GUIDE, endocrinology, rheumatology and dermatology. She co-ordinated the M.Sc. in Hospital Pharmacy from 1995 to 2005 under the auspices of TCD. She retains an academic teaching role with the School of Pharmacy, RCSI where she is Programme Director of Studies of the National Pharmacy Internship Programme. She is a member of the Irish Medication Safety Network, the Hospital Pharmacists Association of Ireland and the 2012 Hospital Pharmacy Assessment Group (PSI). Since 2005 she has been involved in the appraisal of the cost-effectiveness of new technologies for the centre.
|Dr. Susanne Schmitz Dipl.Math, PhD
Dr. Susanne Schmitz is an Assistant Professor in the department of Pharmacology and Therapeutics in Trinity College Dublin. She holds a PhD from the department of Statistics, Trinity College Dublin, for her research on Bayesian methods for evidence synthesis and decision making in Health Technology Assessments. Susanne graduated in Mathematics from RWTH Aachen University in Germany. Her research interests are Bayesian biostatistics, evidence synthesis, meta-analytical methods such as mixed treatment comparison models as well as the role of uncertainty in decision theory and multiple criteria decision analysis. She has worked on applications related to rheumatoid arthritis, multiple sclerosis, hepatitis C and rotavirus modelling
|Dr. Cara Usher BSc, PhD
Dr. Cara Usher is Senior Research Fellow at the National Centre for Pharmacoeconomics. Dr. Cara Usher is Senior Research Fellow at the National Centre for Pharmacoeconomics. She holds a PhD (Pharmacology) from University College Dublin and a post-graduate diploma in Health Economics from the University of York. Overall her work has focused on evaluation of healthcare technologies, education about the evaluation process and examining the effects of reimbursement decisions through a national primary care prescription database. Her research interests include analysis of pharmaceutical policy interventions and their impact on prescribing in the community. She holds a new investigator award from the International society for pharmacoeconomics and outcomes research (ISPOR, 2008) and is a visiting research fellow at Trinity College Dublin.
|Prof. Cathal Walsh MA, PhD
Prof. Cathal Walsh is a Professor in Statistics at Trinity College Dublin and a HRB Research Leader in Health Decision Science. Specific areas in which he has used his expertise are in the modelling of heterogeneity using latent variable models and in combining evidence from multiple sources. He has held visiting appointments in Bayesian groups in Australia and the United States. He contributes to the statistical societies in the UK and Ireland and is currently a member of the Council of the Royal Statistical Society. He is a Statistical Editor for the Cochrane Collaboration and has served as Associate Editor for statistics journals. He is an advisor to the National Centre for Pharmacoeconomics on statistical methodology for Health Technology Assessment.
|Dr. Arthur White, BA (Mod), PhD
Dr. Arthur White is a statistician at the National Centre for Pharmacoeconomics,and an Assistant Professor in the discipline of Statistics in the School of Computer Science and Statistics in Trinity College Dublin. Arthur is a Mathematics graduate of Trinity College Dublin, receiving his degree in 2009. He holds a PhD from the School of Mathematics and Statistics in University College Dublin, for research into latent variable models for multivariate and network data. This work was undertaken as a member of Clique, an SFI funded strategic research cluster. He was previously a postdoctoral researcher for the HRB funded Centre for Health Decision Science. His research interests include Bayesian methods for calibration, model selection and model averaging, and model-based clustering methods. He has worked on applications related to hepatitis C and melanoma, and investigated health service usage patterns among the Irish frail elderly population.